Stantec Inc (STN)
Official siteINDUSTRIALS • ENGINEERING & CONSTRUCTION • NYSE
Market Cap: $9.48B
Last updated: Nov 17, 2026 at 11:06 AM ET
Stantec Inc (STN) P/E Ratio & Valuation Multiples
Stantec (STN) trades at 20.8x trailing earnings and 1.5x sales. Its P/S of 1.5x is below its 5-year median of 1.9x. Its forward P/E is 17.6x. The median P/E across 12 similar companies is 20.3x.
Current Multiples
Its forward P/E is below its trailing P/E, which implies earnings per share about 18.2% higher over the next year. Its free cash flow yield is 6.7%.
| Multiple | Value |
|---|---|
| P/E (trailing) | 20.8x |
| Forward P/E | 17.6x |
| Price to sales | 1.5x |
| Price to book | 2.8x |
| Price to FCF | 14.8x |
| PEG | 1.4 |
| FCF yield | 6.7% |
Historical Medians
Against its 10-year medians, its P/S is 6.3% below 1.6x and its P/B is 15.2% below 3.3x.
| Multiple | Current | 5-year median | 10-year median |
|---|---|---|---|
| P/S | 1.5x | 1.9x | 1.6x |
| P/B | 2.8x | 4.3x | 3.3x |
Valuation History
Over the 10 year ends shown, its P/S ranged from 0.8x in 2018 to 2.3x in 2023.
| Year end | Price | P/S | P/B |
|---|---|---|---|
| 2025 | $94.36 | 2.0x | 4.6x |
| 2024 | $78.45 | 1.6x | 4.4x |
| 2023 | $80.19 | 2.3x | 4.3x |
| 2022 | $47.94 | 1.5x | 3.1x |
| 2021 | $56.25 | 2.2x | 4.0x |
| 2020 | $32.47 | 1.4x | 2.4x |
| 2019 | $28.30 | 0.9x | 2.2x |
| 2018 | $21.86 | 0.8x | 1.7x |
| 2017 | $27.95 | 0.8x | 2.1x |
| 2016 | $25.25 | 0.8x | 2.0x |
P/E history is shown only for companies that report in US dollars.
GNG Valuation
| GNG view | Undervalued |
|---|
GNG fair value is part of GNG Pro. See plans
Frequently Asked Questions About STN
What is STN's forward P/E ratio?
Stantec has a forward P/E ratio of 17.6x.
Is STN stock overvalued?
GNG's valuation label for STN is Undervalued. Its P/E of 20.8x compares with a median of 20.3x across 12 similar companies.
What is STN's price to sales ratio?
Stantec has a price to sales ratio of 1.5x.
What is STN's PEG ratio?
Stantec has a PEG ratio of 1.4.
STN pages: Overview, Dividends, Financials, Valuation, Competitors